ProQR Therapeutics (PRQR) Common Equity (2013 - 2026)
ProQR Therapeutics' Common Equity came in at $92.38 million for the quarter ended Jun 30, 2026, up 21.8% from $75.82 million a year earlier and up 109.9% from the prior quarter.
ProQR Therapeutics (PRQR) Common Equity (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, ProQR Therapeutics' Common Equity was $55.78 million, down 41.8% from the prior year.
- Common Equity carries a five-year compound annual growth rate of -2.9% (years ended Dec 2020 to Dec 2025).
- Going back by year, Common Equity was $95.85 million in the year ended Dec 31, 2024 (+114.1%), $44.77 million in the year ended Dec 31, 2023 (-36.3%), $70.28 million in the year ended Dec 31, 2022 (-48.0%) and $135.04 million in the year ended Dec 31, 2021 (+109.2%).
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Common Equity since the quarter ended Dec 31, 2024.
- Year-over-year, Common Equity increased in five of the last eight quarters, with growth averaging 47.4%.
- The fastest year-over-year change in Common Equity over five years came in the quarter ended Sep 30, 2025 (growth of 143.2%), and the weakest in the quarter ended Sep 30, 2022 (a decline of 54.6%).
- Business Quant data shows PRQR's Common Equity at $44.02 million (quarter ended Mar 31, 2026), $57.47 million (quarter ended Dec 31, 2025) and $66.72 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | ProQR Therapeutics | 145.89 Mn | -314.77 Mn | - | 90.78 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.78 Mn |
| Mar 31, 2026 | 43.09 Mn |
| Dec 31, 2025 | 58.00 Mn |
| Sep 30, 2025 | 66.95 Mn |
| Jun 30, 2025 | 78.55 Mn |
| Mar 31, 2025 | 85.44 Mn |
| Dec 31, 2024 | 92.16 Mn |
| Sep 30, 2024 | 27.90 Mn |
| Jun 30, 2024 | 35.18 Mn |
| Mar 31, 2024 | 37.59 Mn |
| Dec 31, 2023 | 45.81 Mn |
| Sep 30, 2023 | 48.95 Mn |
| Jun 30, 2023 | 55.97 Mn |
| Mar 31, 2023 | 64.01 Mn |
| Dec 31, 2022 | 71.09 Mn |
| Sep 30, 2022 | 66.86 Mn |
| Jun 30, 2022 | 93.37 Mn |
| Mar 31, 2022 | 113.21 Mn |
| Dec 31, 2021 | 129.23 Mn |
| Sep 30, 2021 | 148.52 Mn |
ProQR Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PRQR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();